With a market cap of $36.6 billion, Roper Technologies, Inc. (ROP) designs and develops vertical software and technology-enabled products across the United States and international markets. Its business spans application and network software solutions, as well as specialized technology-enabled products for industries including healthcare, education, finance, and industrial sectors.
The Sarasota, Florida-based company is slated to announce its fiscal Q1 2026 results soon. Ahead of the release, analysts project Roper to report an adjusted DEPS of $4.99, a 4.4% growth from $4.78 in the year-ago quarter. It has exceeded Wall Street's earnings expectations in the past four quarters.
For fiscal 2026, analysts expect Roper Technologies to report an adjusted DEPS of $20.91, a rise of 4.6% from $20 in fiscal 2025. Moreover, adjusted DEPS is anticipated to grow 8.9% year-over-year to $22.77 in fiscal 2027.
Shares of Roper Technologies have decreased 39.8% over the past 52 weeks, lagging behind the broader S&P 500 Index's ($SPX) 16.7% gain and the State Street Technology Select Sector SPDR ETF's (XLK) 29.7% surge over the same period.
Shares of Roper Technologies tumbled 9.6% on Jan. 27 after the company reported Q4 2025 results. It issued a weaker-than-expected 2026 outlook, forecasting revenue growth of ~8% versus Wall Street estimates of ~9%. It also projected 2026 adjusted EPS of $21.30 - $21.55, below the estimate, while Q1 guidance of $4.95 - $5 missed expectations. The decline was further driven by softer demand at its Deltek government contracting unit, concerns about potential U.S. government shutdown impacts, and a slight revenue miss of $2.06 billion.
Analysts' consensus view on ROP stock remains cautiously optimistic, with a "Moderate Buy" rating overall. Out of 18 analysts covering the stock, eight recommend a "Strong Buy," seven "Holds," and three "Strong Sells." This configuration is less bullish than three months ago, with 11 analysts suggesting a "Strong Buy."
The average analyst price target for Roper Technologies is $458.71, indicating a potential upside of 28.9% from the current levels.
On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
More news from Barchart
- Why the Best Space Stock to Buy, as Artemis II Heads for the Moon, Could Be 1 Company You Probably Have Never Heard Of
- Sandisk Was the Top-Performing S&P 500 Stock in Q1. Can SNDK Continue Its Run in Q1?
- Iran Identifies Palantir as a ‘Legitimate Target’ for Threatened Attacks: Should You Sell PLTR Stock Now?
- Boeing Is Stacking Wins, But Is It Still Too Risky to Buy?
